Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 28, 2012 | Promethera Biosciences | $31.4M Debt / Series B | — | ATMI, Boehringer Ingelheim, Financière Spin-off Luxembourgeoise, Life Sciences Research Partners, Mitsui & Co. Global Investment, Sambrinvest, Shire, Sopartec, SRIW, Vesalius Biocapital, VIVES Louvain Technology Fund, Walloon Region |
| Nov 9, 2009 | Promethera Biosciences | $8.0M Series A | Vesalius Biocapital | Capital Croissance, Life Sciences Research Partners, LRM, Sopartec, SRIW, VIVES Louvain Technology Fund |